5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox

Moxetumomab pasudotox (Moxe) is a chimeric protein composed of an anti-CD22 Fv fused to a portion of Pseudomonas exotoxin A and kills CD22-expressing leukemia cells. It is very active in hairy-cell leukemia, but many children with relapsed/refractory acute lymphoblastic leukemia (ALL) either respond...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Proc Natl Acad Sci U S A
Autors principals: Müller, Fabian, Cunningham, Tyler, Stookey, Stephanie, Tai, Chin-Hsien, Burkett, Sandra, Jailwala, Parthav, Stetler Stevenson, Maryalice, Cam, Margaret C., Wayne, Alan S., Pastan, Ira
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2018
Matèries:
PNAS Plus
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5828592/
https://ncbi.nlm.nih.gov/pubmed/29432154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1714512115
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars